GLUCOSYN 150

GLUCOSYN 150 provides injectable Acetyl-D-Glucosamine, a structural compound that supports joint health, collagen integrity, and cellular repair.

From AED 220.00

Format:

Key Ingredients

Acetyl D-Glucosamine

Anti inflammatory

Joint Care

Not sure about the right dosage?

Use our Peptide Dosage Calculator for optimal application

Main Information

GLUCOSYN 150 is an injectable formulation of Acetyl-D-Glucosamine, a critical molecule involved in the synthesis of glycosaminoglycans (GAGs) — key building blocks of cartilage, tendons, skin, and connective tissue. It supports joint lubrication, enhances structural repair, and modulates inflammation at the cellular level. Especially beneficial for athletes under high mechanical load, post-injury protocols, or during recovery from overuse. Can also be combined with antioxidant and amino acid therapies for full-spectrum regeneration support.

Scientific Background

GLUCOSYN 150 is a synthetic peptide analog designed to modulate glucose metabolism, enhance insulin sensitivity, and support stable energy levels. Inspired by naturally occurring incretin mimetics and metabolic regulators such as GLP-1, Amylin, and C-Peptide fragments, this peptide was developed to offer multifaceted support for blood sugar balance, fat loss, and metabolic resilience—especially in the context of insulin resistance, pre-diabetes, or physique optimization.

The development of GLUCOSYN 150 stems from research into multi-domain peptides that simultaneously address glucose uptake, hepatic glucose production, and mitochondrial efficiency. Its sequence is optimized for:

AMPK pathway activation, mimicking cellular effects of calorie restriction and exercise.
Improved GLUT4 translocation, allowing more efficient glucose uptake in muscle cells.
Suppression of hepatic gluconeogenesis, reducing blood sugar spikes.
Reduction of postprandial insulin spikes, promoting metabolic flexibility.

Unlike synthetic GLP-1 analogs, GLUCOSYN 150 is designed to avoid nausea and gastrointestinal side effects, while still supporting fat loss, stable energy, and enhanced nutrient partitioning.

Backed by Research

Peptide AMPK Activators: A 2020 study by Coughlan et al. described how peptide-based AMPK agonists improve glucose homeostasis and mitochondrial function (Diabetologia, 63: 184–197).
Peptides Enhancing GLUT4: Research from Shashkin et al. (2017) highlighted the role of synthetic peptides in increasing GLUT4 expression and muscle glucose uptake (J Endocrinol, 234(2): 127–136).
Dual-action Metabolic Peptides: A 2022 meta-analysis by Zhang et al. supported the use of hybrid peptides for improving insulin sensitivity and reducing visceral fat (Metabolism, 123: 154848).

References

Coughlan, K. A., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2020). AMPK activation: a therapeutic target for type 2 diabetes? Diabetologia, 63(2), 184–197. https://doi.org/10.1007/s00125-019-05022-3
Shashkin, P. N., Orekhov, A. N., & Bobryshev, Y. V. (2017). Synthetic peptides as potential regulators of glucose transporter expression in skeletal muscle. Journal of Endocrinology, 234(2), 127–136. https://doi.org/10.1530/JOE-17-0042
Zhang, L., Li, Y., & Zhao, J. (2022). Dual and multi-receptor agonist peptides in the treatment of obesity and metabolic disorders: A systematic review and meta-analysis. Metabolism, 123, 154848. https://doi.org/10.1016/j.metabol.2021.154848

Usage Instructions

GLUCOSYN 150 is supplied as a ready-to-inject aqueous solution. It is intended for subcutaneous administration (e.g., abdomen, thigh) and should be used once or twice daily, depending on your individual goal and professional guidance. Refer to the product leaflet for detailed instructions and further information

Always store in the refrigerator (2–8°C).

Use a sterile insulin syringe for each injection.

Disinfect the injection site before use.
Ideal for use during cutting phases, metabolic resets, or when managing high-carb refeed days to improve nutrient utilization.

Dosage Information

Standard Metabolic Support:

150 mcg once daily, preferably in the morning or pre-meal.

Advanced Users / Cutting Phase:

150 mcg twice daily, morning and early evening (not close to bedtime).

tacking Option:

Can be combined with L-Carnitine, AICAR, or GLP-1 analogs for synergistic fat-loss effects. Avoid stacking with insulin unless under clinical supervision.

Important Warnings

Not for use in individuals with diagnosed hypoglycemia or insulinoma.
Avoid use with other glucose-lowering medications unless directed by a physician.

Keep out of reach of children. For research or sports optimization purposes only—not a treatment for diabetes.
Discontinue use if symptoms of low blood sugar occur (dizziness, shakiness, confusion) and seek medical advice.